Gloria Smith v. United States

CourtCourt of Appeals for the Eleventh Circuit
DecidedAugust 7, 2023
Docket22-13645
StatusUnpublished

This text of Gloria Smith v. United States (Gloria Smith v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gloria Smith v. United States, (11th Cir. 2023).

Opinion

USCA11 Case: 22-13645 Document: 28-1 Date Filed: 08/07/2023 Page: 1 of 15

[DO NOT PUBLISH] In the United States Court of Appeals For the Eleventh Circuit

____________________

No. 22-13645 Non-Argument Calendar ____________________

GLORIA SMITH, Plaintiff-Appellant, versus UNITED STATES OF AMERICA,

Defendant-Appellee,

DR. KENNEDY OKERE,

Defendant.

____________________ USCA11 Case: 22-13645 Document: 28-1 Date Filed: 08/07/2023 Page: 2 of 15

2 Opinion of the Court 22-13645

Appeal from the United States District Court for the Southern District of Georgia D.C. Docket No. 4:20-cv-00286-RSB-CLR ____________________

Before JORDAN, JILL PRYOR, and BRANCH, Circuit Judges. PER CURIAM: Appellant Gloria Smith brought a lawsuit against the United States under the Federal Tort Claims Act, alleging that Dr. Ken- nedy Okere, a doctor at the Curtis V. Cooper Primary Health Cen- ter (“CVC”), a federally-supported health center, committed med- ical malpractice. According to Smith, Okere prescribed a medica- tion that caused her to have a severe allergic reaction and be hos- pitalized. To support her claim, Smith introduced testimony from an expert who opined that the medication Okere prescribed caused Smith’s allergic reaction. But the district court excluded the ex- pert’s opinion under Daubert v. Merrill Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and then granted summary judgment to the United States. On appeal, Smith challenges the district court’s deci- sions to exclude her expert’s opinion and to grant summary judg- ment to the government. After careful consideration, we affirm. I. Smith, who suffers from high blood pressure, received med- ical care at CVC. In 2016, Smith was prescribed an ACE inhibitor, a type of medication used to treat high blood pressure. After taking USCA11 Case: 22-13645 Document: 28-1 Date Filed: 08/07/2023 Page: 3 of 15

22-13645 Opinion of the Court 3

the medication, Smith had an allergic reaction and needed to go to the hospital. In December 2018, Smith was seen by Okere at CVC. At that appointment, he prescribed the drug lisinopril, an ACE inhibitor, to treat her high blood pressure. Inexplicably, Okere selected this medication, despite multiple warnings in Smith’s medical records stating that she was allergic to ACE inhibitors. For a four-month period, Smith dutifully took lisinopril every day. In the afternoon of April 8, 2019, Smith experienced a severe allergic reaction. She felt her tongue swelling inside her mouth and her throat closing. She immediately went to the hospital. At the hospital, Smith was diagnosed with angioedema. An- gioedema is a condition that involves the swelling of tissue in the lips, tongue, face, hands, or feet. In rare cases, this swelling can lead to airway obstruction and potentially death. At the hospital, Smith’s condition initially improved. But she quickly took a turn for the worse. She was admitted to the intensive care unit and ended up in a medically induced coma. After approx- imately two weeks, Smith’s condition improved, and she was re- leased from the hospital. Medical records from the hospital show that Smith reported taking several medications at home on the day she experienced the allergic reaction, including lisinopril and aspi- rin. Smith sued the United States, bringing a claim for medical malpractice under the Federal Tort Claims Act, 28 U.S.C. §§ 1346, USCA11 Case: 22-13645 Document: 28-1 Date Filed: 08/07/2023 Page: 4 of 15

4 Opinion of the Court 22-13645

2671 et seq. 1 She alleged that Okere committed medical malpractice by prescribing her lisinopril, which caused her allergic reaction. During the litigation, Smith identified Dr. James Cornwell, Jr., an experienced primary care physician, as an expert whose opin- ions she would be relying on in the case. In his expert report, Corn- well opined that Okere and CVC deviated from the applicable standard of care. He explained that it was a “breach of the standard of care to prescribe a medication to which the patient has a known allergy or adverse reaction.” Doc. 33 at 8. 2 In addition to providing an opinion on the standard of care, Cornwell also opined about causation. In his expert report, his en- tire opinion on causation consisted of one sentence, which stated that “[w]ithin a reasonable degree of medical certainty, the afore- mentioned negligent acts and omissions of CVC and . . . Okere caused . . . Smith to suffer a severe, life-threatening adverse

1 The parties agree that the Federal Tort Claims Act provides the exclusive remedy for Smith’s malpractice claim. Because Okere was a physician working as a contractor for CVC and the facility was a federally-supported health cen- ter, Okere is “deemed to be an employee of the Public Health Service.” See 42 U.S.C. § 233(g)(1)(A). Federal law specifies that the Federal Tort Claims Act provides the “exclusive” remedy “for damage for personal injury . . . resulting from the performance of medical . . . functions . . . by any . . . employee of the Public Health Service.” Id. § 233(a), (g)(1)(A); see Allen v. Christenberry, 327 F.3d 1290, 1294 (11th Cir. 2003) (describing statutory scheme). 2 “Doc.” numbers refer to the district court’s docket entries. USCA11 Case: 22-13645 Document: 28-1 Date Filed: 08/07/2023 Page: 5 of 15

22-13645 Opinion of the Court 5

reaction, including angioedema, for which she required emergency medical care and hospitalization.” Id. The government moved to exclude Cornwell’s opinion about causation under Daubert. First, it argued that Cornwell was not qualified because he did not have any experience in determin- ing the causes of angioedema. Second, it asserted that Cornwell’s opinion about causation was not based on a reliable methodology. According to the government, Cornwell’s “report display[ed] no methodology on causation” because his entire discussion of causa- tion consisted of a single sentence and was entirely “devoid of fac- tual or analytical support.” Doc. 35 at 10 (internal quotation marks omitted). The government pointed out that Cornwell did not “note or rule out other possible causes for [Smith’s] illness.” Id. at 11. The government argued that if Cornwell’s opinion on cau- sation was excluded, the court should grant summary judgment. It explained under the Federal Tort Claims Act, Georgia law gov- erned because the allegedly negligent act—prescribing lisinopril— occurred in Georgia. See 28 U.S.C. § 1346(b)(1). And under Georgia law, to prove proximate causation for a medical malpractice claim, a plaintiff must present expert testimony. If Cornwell’s opinion on causation was excluded, the government reasoned, it would be en- titled to summary judgment because Smith would have no expert testimony regarding causation. Smith opposed the government’s motions to exclude Corn- well’s causation opinion and for summary judgment. With her USCA11 Case: 22-13645 Document: 28-1 Date Filed: 08/07/2023 Page: 6 of 15

6 Opinion of the Court 22-13645

opposition, she filed a supplemental affidavit from Cornwell. In the affidavit, he provided more information about his qualifications, including that he previously had treated between 20 and 30 patients suffering from angioedema. He also provided more details about the relationship be- tween ACE inhibitors and angioedema.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Roderic R. McDowell v. Pernell Brown
392 F.3d 1283 (Eleventh Circuit, 2004)
Rink v. Cheminova, Inc.
400 F.3d 1286 (Eleventh Circuit, 2005)
Louise Cook v. Sheriff of Monroe County
402 F.3d 1092 (Eleventh Circuit, 2005)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Allen v. Christenberry
327 F.3d 1290 (Eleventh Circuit, 2003)
Knight v. West Paces Ferry Hospital, Inc.
585 S.E.2d 104 (Court of Appeals of Georgia, 2003)
Porter v. Guill
681 S.E.2d 230 (Court of Appeals of Georgia, 2009)
Rhonda Williams v. Mosaic Fertilizer, LLC
889 F.3d 1239 (Eleventh Circuit, 2018)
Brenda Smelter v. Souther Home Care Services Inc.
904 F.3d 1276 (Eleventh Circuit, 2018)
United States v. David Ming Pon
963 F.3d 1207 (Eleventh Circuit, 2020)
Does 1 Through 976 v. Chiquita Brands International, Inc.
47 F.4th 1278 (Eleventh Circuit, 2022)
Stevens v. Battelle Memorial Institute
488 F.3d 896 (Eleventh Circuit, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Gloria Smith v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gloria-smith-v-united-states-ca11-2023.